Vir Biotechnology, Inc. (VIR)
USD 5.8
(3.3%)
USD 5.8
(3.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 86.18 Million | 1.58 Billion | 1.08 Billion | 67.24 Million | 711 Thousand | 868 Thousand |
| Cost of Revenue | 2.76 Million | 146.31 Million | 65.86 Million | 301.57 Million | 148.47 Million | 100.22 Million |
| Gross Profit | 83.41 Million | 1.43 Billion | 1.02 Billion | -234.33 Million | -147.76 Million | -99.36 Million |
| Operating Expenses | 767.72 Million | 601.08 Million | 600.45 Million | 364.22 Million | 178.69 Million | 119.56 Million |
| Selling, General and Administrative Expenses | 174.04 Million | 161.76 Million | 160.79 Million | 70.93 Million | 37.59 Million | 29.13 Million |
| Research and Development Expenses | 589.67 Million | 474.64 Million | 448 Million | 302.41 Million | 148.47 Million | 100.22 Million |
| Other Expenses | - | -35.32 Million | -8.34 Million | -9.12 Million | -7.38 Million | -212 Thousand |
| Cost and Expenses | 770.48 Million | 747.4 Million | 666.31 Million | 364.22 Million | 178.69 Million | 119.56 Million |
| Operating Income | -684.3 Million | 833.06 Million | 276.89 Million | -296.98 Million | -177.97 Million | -118.69 Million |
| Interest Expense | - | 183.14 Million | - | - | - | - |
| Income Tax Expense | -13.07 Million | 238.44 Million | 21.21 Million | 54 Thousand | 154 Thousand | -480 Thousand |
| Earnings before Tax | -628.19 Million | 754.28 Million | 549.8 Million | -298.61 Million | -174.52 Million | -116.36 Million |
| Net Income | -615.06 Million | 515.83 Million | 528.58 Million | -298.66 Million | -174.68 Million | -115.88 Million |
| Earnings Per Share Basic | -4.59 | 3.89 | 4.07 | -2.51 | -1.62 | -1.20 |
| Earnings Per Share Diluted | -4.59 | 3.83 | 3.96 | -2.51 | -1.62 | -1.20 |
| Weighted Average Shares Outstanding | 134.13 Million | 132.6 Million | 129.88 Million | 119.15 Million | 107.64 Million | 96.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 134.13 Million | 134.81 Million | 133.43 Million | 119.15 Million | 107.64 Million | 96.91 Million |
| Gross Margin | 0.97 | 0.91 | 0.94 | -3.48 | -207.82 | -114.47 |
| EBIT Margin | -7.94 | 0.60 | 0.26 | -4.42 | -250.32 | -133.57 |
| Profit Margin | -7.14 | 0.33 | 0.49 | -4.44 | -245.69 | -133.51 |
| EBITDA | -684.3 Million | 833.06 Million | 420.75 Million | -289.79 Million | -173.46 Million | -115.93 Million |
| Earnings Before Tax Margin | -7.94 | 0.53 | 0.25 | -4.42 | -250.32 | -136.74 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.38 Million | 3.07 Million | 56.37 Million | 16.78 Million | 86.18 Million | -4.09 Million |
| Cost of Revenue | 50 Thousand | 4.31 Million | 4.57 Million | 5.27 Million | 22.21 Million | 38 Thousand |
| Gross Profit | 2.33 Million | -1.23 Million | 51.8 Million | 11.51 Million | 63.96 Million | -4.13 Million |
| Operating Expenses | 220.92 Million | 128.12 Million | 104.28 Million | 128.62 Million | 724.96 Million | 182.59 Million |
| Selling, General and Administrative Expenses | 25.74 Million | 30.26 Million | 36.27 Million | 39.09 Million | - | 41.08 Million |
| Research and Development Expenses | 195.17 Million | 97.86 Million | 68 Million | 89.53 Million | - | 148.25 Million |
| Other Expenses | 12.71 Million | -535 Thousand | -287 Thousand | -1.48 Million | -8.99 Million | 882 Thousand |
| Cost and Expenses | 220.97 Million | 132.44 Million | 108.85 Million | 133.9 Million | 747.18 Million | 182.63 Million |
| Operating Income | -218.59 Million | -129.36 Million | -52.48 Million | -117.11 Million | -661 Million | -186.73 Million |
| Interest Expense | - | - | - | 239 Thousand | - | - |
| Income Tax Expense | 177 Thousand | -1.51 Million | 276 Thousand | -4.78 Million | -13.07 Million | -3.21 Million |
| Earnings before Tax | -213.54 Million | -139.89 Million | -65 Million | -120.75 Million | -628.19 Million | -166.62 Million |
| Net Income | -213.71 Million | -138.37 Million | -65.27 Million | -115.97 Million | -615.06 Million | -163.41 Million |
| Earnings Per Share Basic | -1.56 | -1.02 | -0.48 | -0.86 | - | -1.22 |
| Earnings Per Share Diluted | -1.56 | -1.02 | -0.48 | -0.86 | - | -1.22 |
| Weighted Average Shares Outstanding | 136.65 Million | 136.23 Million | 135.28 Million | 134.6 Million | 134.13 Million | 134.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 136.65 Million | 136.23 Million | 135.28 Million | 134.6 Million | 134.13 Million | 134.28 Million |
| Gross Margin | 0.98 | -0.40 | 0.92 | 0.69 | 0.74 | 1.01 |
| EBIT Margin | -89.72 | -40.68 | -0.85 | -6.71 | - | 44.91 |
| Profit Margin | -89.80 | -45.00 | -1.16 | -6.91 | -7.14 | 39.88 |
| EBITDA | -213.54 Million | -125.1 Million | -47.96 Million | -112.63 Million | - | -184.02 Million |
| Earnings Before Tax Margin | -91.85 | -42.07 | -0.93 | -6.98 | -7.67 | 45.57 |
VNNVF
NEFB
CBRE
CHAMBLFERT
600796
GDPHF